These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3223647)
21. Investigation of malignant hyperthermia in Sweden. Ranklev E; Fletcher R Acta Anaesthesiol Scand; 1986 Nov; 30(8):693-6. PubMed ID: 3811813 [TBL] [Abstract][Full Text] [Related]
22. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia? Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863 [TBL] [Abstract][Full Text] [Related]
23. [Malignant hyperthermia and appendicular sepsis. Can they be differentiated during surgical procedure?]. Strecker G; Adnet P; Forget AP; Krivosic-Horber R Ann Fr Anesth Reanim; 1997; 16(3):234-8. PubMed ID: 9732771 [TBL] [Abstract][Full Text] [Related]
24. [Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment]. Johannsen S; Schuster F Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):527-537. PubMed ID: 31525786 [TBL] [Abstract][Full Text] [Related]
25. Malignant hyperthermia. Rosenberg H; Davis M; James D; Pollock N; Stowell K Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235 [TBL] [Abstract][Full Text] [Related]
26. Should all children with suspected or confirmed malignant hyperthermia susceptibility be admitted after surgery? A 10-year review. Yentis SM; Levine MF; Hartley EJ Anesth Analg; 1992 Sep; 75(3):345-50. PubMed ID: 1510254 [TBL] [Abstract][Full Text] [Related]
27. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia. Dexter F; Epstein RH; Wachtel RE; Rosenberg H Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale]. von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423 [TBL] [Abstract][Full Text] [Related]
29. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135 [TBL] [Abstract][Full Text] [Related]
30. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method]. Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965 [TBL] [Abstract][Full Text] [Related]
31. [Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997]. Hartung E; Anetseder M; Olthoff D; Deutrich C; Lehmann-Horn F; Baur C; Mortier W; Tzanova I; Doetsch S; Quasthoff S; Hofmann M; Schwefler B; Jantzen JP; Wappler F; Scholz J Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):238-43. PubMed ID: 9617422 [TBL] [Abstract][Full Text] [Related]
32. Malignant hyperthermia in Mazovia Province - are we adequately prepared? Cieniewicz A; Trzebicki J Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281 [TBL] [Abstract][Full Text] [Related]
33. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546 [TBL] [Abstract][Full Text] [Related]
34. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Brandom BW; Larach MG; Chen MS; Young MC Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281 [TBL] [Abstract][Full Text] [Related]
35. Investigation of malignant hyperthermia in Denmark and Sweden. Ording H; Ranklev E; Fletcher R Br J Anaesth; 1984 Nov; 56(11):1183-90. PubMed ID: 6487440 [TBL] [Abstract][Full Text] [Related]
36. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone]. Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864 [TBL] [Abstract][Full Text] [Related]
38. Genetic effects on the variability of the halothane and caffeine muscle contracture tests. Urwyler A; Censier K; Kaufmann MA; Drewe J Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475 [TBL] [Abstract][Full Text] [Related]
39. [Malignant hyperthermia in a child with acute lymphatic leukemia]. Sailer R; Hinrichs B; Mantel K Anaesthesist; 1991 May; 40(5):298-301. PubMed ID: 1867372 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]